Cart

“Symptomatic Remission and Cognitive Impairment in First-Episode Schizophrenia: A Prospective 3-Year Follow-Up Study PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Product	Price	Quantity	Subtotal
×	Cognitive-Behavioral Group Therapy for Panic Disorder in the General Clinical Setting: A Naturalistic Study With 1-Year Follow-Up PDF	$40.00	Cognitive-Behavioral Group Therapy for Panic Disorder in the General Clinical Setting: A Naturalistic Study With 1-Year Follow-Up PDF quantity	$40.00
×	Tools to Improve Differential Diagnosis of Bipolar Disorder in Primary Care PDF	$40.00	Tools to Improve Differential Diagnosis of Bipolar Disorder in Primary Care PDF quantity	$40.00
×	Relations Among Psychopathology, Substance Use, and Physical Pain Experiences in Methadone-Maintained Patients PDF	$40.00	Relations Among Psychopathology, Substance Use, and Physical Pain Experiences in Methadone-Maintained Patients PDF quantity	$40.00
×	Neuroleptic Malignant Syndrome After Exposure to Asenapine: A Case Report PDF	$40.00	Neuroleptic Malignant Syndrome After Exposure to Asenapine: A Case Report PDF quantity	$40.00
×	Gender Incongruence Unmasked by Manic Switch During COVID-19 Infection PDF	$40.00	Gender Incongruence Unmasked by Manic Switch During COVID-19 Infection PDF quantity	$40.00
×	Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study PDF	$40.00	Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study PDF quantity	$40.00
×	Clinical Correlates of Zolpidem-Associated Complex Sleep-Related Behaviors: Age Effect PDF	$40.00	Clinical Correlates of Zolpidem-Associated Complex Sleep-Related Behaviors: Age Effect PDF quantity	$40.00
×	Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement PDF	$40.00	Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement PDF quantity	$40.00
×	Suicide in Prisoners: A Systematic Review of Risk Factors PDF	$40.00	Suicide in Prisoners: A Systematic Review of Risk Factors PDF quantity	$40.00
×	The Implications of Genetic Studies of Major Mood Disorders for Clinical Practice PDF	$40.00	The Implications of Genetic Studies of Major Mood Disorders for Clinical Practice PDF quantity	$40.00
×	Traumatic Grief Treatment: Case Histories of 4 Patients. PDF	$40.00	Traumatic Grief Treatment: Case Histories of 4 Patients. PDF quantity	$40.00
×	Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient PDF	$40.00	Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient PDF quantity	$40.00
×	Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine PDF	$40.00	Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine PDF quantity	$40.00
×	The Integration of Palliative Care Into Medical Care PDF	$40.00	The Integration of Palliative Care Into Medical Care PDF quantity	$40.00
×	Mirtazapine Augmentation in the Treatment of Refractory Depression PDF	$40.00	Mirtazapine Augmentation in the Treatment of Refractory Depression PDF quantity	$40.00
×	Symptomatic Remission and Cognitive Impairment in First-Episode Schizophrenia: A Prospective 3-Year Follow-Up Study PDF	$40.00	Symptomatic Remission and Cognitive Impairment in First-Episode Schizophrenia: A Prospective 3-Year Follow-Up Study PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Join Now

Cart totals

Subtotal	$640.00
Total	$640.00

Proceed to checkout

Cart

Cart totals

ELSEWHERE:

FOLLOW US:

Cart

Cart totals

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles